856 Shares in The Cigna Group (NYSE:CI) Purchased by Courier Capital LLC

Courier Capital LLC acquired a new position in shares of The Cigna Group (NYSE:CI - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 856 shares of the health services provider's stock, valued at approximately $282,000.

Several other large investors have also recently bought and sold shares of CI. TCTC Holdings LLC acquired a new stake in shares of The Cigna Group during the fourth quarter worth $25,000. Collier Financial acquired a new stake in shares of The Cigna Group in the 4th quarter valued at approximately $32,000. Putney Financial Group LLC acquired a new stake in shares of The Cigna Group in the 4th quarter valued at approximately $36,000. Compagnie Lombard Odier SCmA bought a new position in The Cigna Group during the 4th quarter worth approximately $37,000. Finally, Transce3nd LLC acquired a new position in The Cigna Group during the fourth quarter valued at approximately $38,000. Institutional investors and hedge funds own 86.99% of the company's stock.

Analysts Set New Price Targets

CI has been the topic of a number of recent analyst reports. Mizuho lifted their price target on shares of The Cigna Group from $360.00 to $384.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Piper Sandler lifted their target price on The Cigna Group from $348.00 to $374.00 and gave the stock an "overweight" rating in a report on Monday, May 5th. Guggenheim reissued a "buy" rating and issued a $388.00 target price on shares of The Cigna Group in a research note on Friday, May 23rd. Royal Bank of Canada reaffirmed an "outperform" rating and set a $371.00 price target on shares of The Cigna Group in a research report on Tuesday, June 3rd. Finally, Barclays reissued an "overweight" rating and set a $385.00 target price (up from $382.00) on shares of The Cigna Group in a research note on Monday, June 2nd. Two research analysts have rated the stock with a hold rating, sixteen have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, The Cigna Group has an average rating of "Buy" and an average target price of $380.39.

The Cigna Group Stock Up 0.5%

NYSE:CI traded up $1.66 on Friday, hitting $317.03. 1,866,265 shares of the company's stock were exchanged, compared to its average volume of 1,712,757. The firm has a 50-day moving average price of $322.23 and a 200-day moving average price of $308.70. The Cigna Group has a 52 week low of $262.03 and a 52 week high of $370.83. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72. The company has a market cap of $84.69 billion, a P/E ratio of 25.90, a price-to-earnings-growth ratio of 0.98 and a beta of 0.44.

The Cigna Group (NYSE:CI - Get Free Report) last released its earnings results on Friday, May 2nd. The health services provider reported $6.74 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.35 by $0.39. The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. The business had revenue of $65.45 billion for the quarter, compared to analyst estimates of $60.39 billion. During the same quarter in the prior year, the company posted $6.47 earnings per share. The Cigna Group's revenue was up 14.4% on a year-over-year basis. As a group, analysts expect that The Cigna Group will post 29.77 EPS for the current fiscal year.

The Cigna Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 18th. Investors of record on Tuesday, June 3rd will be issued a dividend of $1.51 per share. The ex-dividend date is Tuesday, June 3rd. This represents a $6.04 dividend on an annualized basis and a yield of 1.91%. The Cigna Group's payout ratio is 33.44%.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.